Rapport Therapeutics, Inc. (RAPP) Revenue (2026)
Rapport Therapeutics (RAPP) posted quarterly Revenue of $20.0 million for Q1 2026.
Rapport Therapeutics, Inc. (RAPP) Revenue (2026) Analysis & Trends
Rapport Therapeutics has disclosed Revenue across 1 years of filings, most recently posting $20.0 million for Q1 2026.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.00 Mn |